InnovAge (INNV) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free INNV Stock Alerts $3.91 +0.11 (+2.89%) (As of 05:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings InnovAge Short Interest DataCurrent Short Volume4,000 sharesPrevious Short Volume5,800 sharesChange Vs. Previous Month-31.03%Dollar Volume Sold Short$4,920.00Short Interest Ratio / Days to Cover0.1Last Record DateFebruary 14, 2020Outstanding Shares135,899,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume8,567 sharesAverage Trading Volume23,521 sharesToday's Volume Vs. Average36% Short Selling InnovAge ? Sign up to receive the latest short interest report for InnovAge and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINNV Short Interest Over TimeINNV Days to Cover Over TimeINNV Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. InnovAge Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/14/20204,000 shares $4,920.00 -31.0%N/A0.1 $1.23 1/31/20205,800 shares $6,670.00 +480.0%N/A0.2 $1.15 1/15/20201,000 shares $950.00 No ChangeN/A0.1 $0.95 12/31/20191,000 shares $902.40 -9.1%N/A0 $0.90 INNV Short Interest - Frequently Asked Questions What is InnovAge's current short interest? Short interest is the volume of InnovAge shares that have been sold short but have not yet been closed out or covered. As of February 14th, traders have sold 4,000 shares of INNV short. Learn More on InnovAge's current short interest. Is InnovAge's short interest increasing or decreasing? InnovAge saw a drop in short interest during the month of February. As of February 14th, there was short interest totaling 4,000 shares, a drop of 31.0% from the previous total of 5,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InnovAge's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to InnovAge: OmniAb, Inc. (5.05%), Jin Medical International Ltd. (0.83%), Korro Bio, Inc. (2.58%), Valneva SE (0.07%), Calliditas Therapeutics AB (publ) (0.02%), Unrivaled Brands, Inc. (0.00%), Altimmune, Inc. (28.73%), Castle Biosciences, Inc. (5.32%), Phibro Animal Health Co. (3.10%), Absci Co. (10.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($11.87 billion), Charter Communications, Inc. ($5.15 billion), Microchip Technology Incorporated ($2.98 billion), Match Group, Inc. ($2.25 billion), The Charles Schwab Co. ($2.09 billion), Simon Property Group, Inc. ($2.06 billion), Tiffany & Co. ($1.81 billion), Hormel Foods Co. ($1.66 billion), Omnicom Group Inc. ($1.61 billion), and International Flavors & Fragrances Inc. ($1.54 billion). View all of the most shorted stocks. What does it mean to sell short InnovAge stock? Short selling INNV is an investing strategy that aims to generate trading profit from InnovAge as its price is falling. INNV shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InnovAge? A short squeeze for InnovAge occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INNV, which in turn drives the price of the stock up even further. How often is InnovAge's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INNV, twice per month. The most recent reporting period available is February, 14 2020. More Short Interest Resources from MarketBeat Related Companies: OmniAb Short Interest Jin Medical International Short Interest Korro Bio Short Interest Valneva Short Interest Calliditas Therapeutics AB (publ) Short Interest Unrivaled Brands Short Interest Altimmune Short Interest Castle Biosciences Short Interest Phibro Animal Health Short Interest Absci Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INNV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press